Olaparib Combined with DDR Inhibitors Effectively Prevents EMT and Affects miRNA Regulation in TP53-Mutated Epithelial Ovarian Cancer Cell Lines
Patrycja Gralewska(University of Łódź), Aneta Rogalska(University of Łódź)
Cited by 5
Related Papers
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model
|International Journal of Molecular Sciences|2025|1
Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer
|International Journal of Molecular Sciences|2026|0